139 related articles for article (PubMed ID: 1978694)
1. Nonpeptide angiotensin II receptor antagonists: a novel class of antihypertensive agents.
Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL
Blood Vessels; 1990; 27(2-5):295-300. PubMed ID: 1978694
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide angiotensin II receptor antagonists.
Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL
Am J Hypertens; 1990 Aug; 3(8 Pt 1):599-604. PubMed ID: 2222950
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.
Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL
Hypertension; 1991 Nov; 18(5 Suppl):III136-42. PubMed ID: 1937677
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
Chiu AT; Duncia JV; McCall DE; Wong PC; Price WA; Thoolen MJ; Carini DJ; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1989 Sep; 250(3):867-74. PubMed ID: 2778716
[TBL] [Abstract][Full Text] [Related]
5. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
6. Rationale for the chemical development of angiotensin II receptor antagonists.
Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
[TBL] [Abstract][Full Text] [Related]
7. The discovery of a new class of highly specific nonpeptide angiotensin II receptor antagonists.
Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Johnson AL; Wexler RR
Am J Hypertens; 1991 Apr; 4(4 Pt 2):275S-281S. PubMed ID: 1854452
[TBL] [Abstract][Full Text] [Related]
8. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists.
Chiu AT; Carini DJ; Duncia JV; Leung KH; McCall DE; Price WA; Wong PC; Smith RD; Wexler RR; Timmermans PB
Biochem Biophys Res Commun; 1991 May; 177(1):209-17. PubMed ID: 2043107
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
[TBL] [Abstract][Full Text] [Related]
11. Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.
Wong PC; Price WA; Chiu AT; Carini DJ; Duncia JV; Johnson AL; Wexler RR; Timmermans PB
Hypertension; 1990 Jun; 15(6 Pt 2):823-34. PubMed ID: 2351436
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803.
Wong PC; Price WA; Chiu AT; Thoolen MJ; Duncia JV; Johnson AL; Timmermans PB
Hypertension; 1989 May; 13(5):489-97. PubMed ID: 2656519
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB
J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502
[TBL] [Abstract][Full Text] [Related]
15. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.
Carini DJ; Duncia JV; Johnson AL; Chiu AT; Price WA; Wong PC; Timmermans PB
J Med Chem; 1990 May; 33(5):1330-6. PubMed ID: 2329554
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
